RedHill Biopharma Ltd. reports

Company location
Tel Aviv, Israel
RedHill Biopharma Ltd. has filed 1,021 SEC EDGAR filings since 01 Oct 2012

SEC filing history

Showing 126-150 of 1,000 matching filings.

Per page
25
Current page
6
6-K File 001-35773

6-K

Filing date
16 Aug 2024
Reporting date
16 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-281417

UPLOAD filing

Filing date
15 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-268713

424B3

Filing date
13 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
13 Aug 2024
Reporting date
13 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
F-3 File 333-281417

F-3

Filing date
09 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D File 005-87280

SCHEDULE 13D filing

Filing date
07 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-268713

424B3

Filing date
07 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 Aug 2024
Reporting date
06 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
01 Aug 2024
Reporting date
01 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
22 Jul 2024
Reporting date
22 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
09 Jul 2024
Reporting date
09 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-280327

S-8

Filing date
20 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
03 Jun 2024
Reporting date
03 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
06 May 2024
Reporting date
06 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
24 Apr 2024
Reporting date
24 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276979

EFFECT filing

Filing date
22 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-276979

POS AM

Filing date
18 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
08 Apr 2024
Reporting date
08 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
04 Apr 2024
Reporting date
04 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
03 Apr 2024
Reporting date
03 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258259

424B5

Filing date
02 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-35773

6-K

Filing date
02 Apr 2024
Reporting date
02 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .